Patients with polycythemia vera have worst impairment of quality of life among patients with newly diagnosed myeloproliferative neoplasms
Johanna Abelsson(NU Hospital Group), Peter Johansson(Linköping University), Ruben A. Mesa(Atrium Health Wake Forest Baptist), Jan Samuelsson(Karolinska University Hospital), Björn Andréasson(NU Hospital Group), Robyn M. Emanuel(Centre Hospitalier Universitaire de Grenoble), Elisabeth Ejerblad(Uppsala University), Berit Johansson(Södra Älvsborg Hospital), Malin Hultcrantz(United States Fish and Wildlife Service)
Cited by 55
Related Papers
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs
|Journal of Clinical Oncology|2012|461
GPRC5D-Targeted CAR T Cells for Myeloma
|New England Journal of Medicine|2022|383